triiodothyronine has been researched along with tamoxifen in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (19.35) | 18.7374 |
| 1990's | 11 (35.48) | 18.2507 |
| 2000's | 8 (25.81) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Allegra, JC; Lippman, ME | 1 |
| Albaladejo, V; Andre, J; Joly-Pharaboz, MO; Nicolas, B; Zhou-Li, F | 1 |
| DiPippo, VA; Powers, CA | 2 |
| Brooks, AR; Old, RW; Sweeney, GE | 1 |
| Baulieu, EE; Baville, F; Bideux, G; Binart, N; Chambraud, B; Mercier-Bodard, C | 1 |
| Hsiao, WL; Lopez, CA; Weinstein, IB | 1 |
| Baulieu, EE; Mercier-Bodard, C | 1 |
| Beastall, GH; Gordon, D; McArdle, CS; Thomson, JA | 1 |
| Dawson, MI; Feng, P; Fontana, JA; Li, XS; Rishi, AK; Shao, ZM; Sheikh, MS; Wilber, JF | 1 |
| DiPippo, VA; Lindsay, R; Powers, CA | 1 |
| Gilchrist, CA; MacDonald, RG; Park, JH; Shull, JD | 1 |
| Brentani, MM; Nogueira, CR | 1 |
| Fujimoto, N; Goto, T; Ito, A; Nakatani, T; Roy, G | 1 |
| Aakvaag, A; Anker, GB; Lien, EA; Lønning, PE | 1 |
| Fitts, JM; Klein, RM; Powers, CA | 2 |
| Baxter, JD; Greene, GL; Kushner, PJ; Lopez, GN; Shinsako, JH; Webb, P | 1 |
| Gregoraszczuk, EL | 1 |
| Braverman, LE; Carroll, JS; Lawrence, JE; Marqusee, E; Seely, EW | 1 |
| Bandiera, SM; Ickenstein, LM | 1 |
| Fujimoto, N; Jinno, N; Kitamura, S | 1 |
| Baracat, EC; Calió, PL; de Araujo, LF; Haidar, MA; Oliveira-Filho, RM; Simões, Mde J; Simões, RS; Soares, JM | 1 |
| Brentani, MM; Conde, SJ; Katayama, ML; Luvizotto, RA; Nogueira, CR; Síbio, MT | 1 |
| Brentani, MM; Cestari, SH; Clara, S; Conde, SJ; Figueiredo, NB; Katayama, ML; Nogueira, CR; Padovani, CR | 1 |
1 review(s) available for triiodothyronine and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for triiodothyronine and tamoxifen
| Article | Year |
|---|---|
The effect of droloxifene and estrogen on thyroid function in postmenopausal women.
Topics: Aged; Cross-Over Studies; Double-Blind Method; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Postmenopause; Reference Values; Tamoxifen; Thyroid Function Tests; Thyroid Gland; Thyroid Hormones; Thyrotropin; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 2000 |
29 other study(ies) available for triiodothyronine and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Growth of a human breast cancer cell line in serum-free hormone-supplemented medium.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cell Line; Cell Survival; Culture Media; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Humans; Insulin; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Tamoxifen; Transferrin; Triiodothyronine | 1978 |
Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Topics: Breast Neoplasms; Cell Division; DNA, Neoplasm; Estradiol; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor I; Pituitary Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Thyroid Hormone; RNA, Messenger; Tamoxifen; Transcription, Genetic; Triiodothyronine; Tumor Cells, Cultured | 1992 |
Estrogen induction of growth hormone in the thyroidectomized rat.
Topics: Animals; Diethylstilbestrol; Estradiol; Estrogen Antagonists; Estrogens; Female; Growth Hormone; Rats; Rats, Inbred Strains; Tamoxifen; Thyroidectomy; Triiodothyronine | 1991 |
Activity of a cloned Xenopus albumin gene promoter in the homologous frog oocyte system.
Topics: Animals; Cloning, Molecular; Dexamethasone; Female; Liver; Male; Oocytes; Poly A; Promoter Regions, Genetic; RNA; RNA, Messenger; Serum Albumin; Tamoxifen; Transcription, Genetic; Transformation, Genetic; Triiodothyronine; Xenopus laevis | 1988 |
Regulation of SBP synthesis in human cancer cell lines by steroid and thyroid hormones.
Topics: Blotting, Northern; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line; Estradiol; Female; Gene Expression Regulation; Humans; Liver Neoplasms; Male; Nucleic Acid Hybridization; Prostatic Neoplasms; RNA, Messenger; Sex Hormone-Binding Globulin; Tamoxifen; Triiodothyronine; Tumor Cells, Cultured; Uterine Neoplasms | 1989 |
Effects of triiodothyronine and tamoxifen on cell transformation induced by an activated c-Ha-ras oncogene.
Topics: Animals; Blotting, Southern; Cell Line; Cell Transformation, Neoplastic; Clone Cells; DNA; Genes, ras; Tamoxifen; Tetradecanoylphorbol Acetate; Transfection; Triiodothyronine | 1989 |
Hormonal control of SBP in human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line; Dexamethasone; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Hormones; Humans; Liver Neoplasms; Sex Hormone-Binding Globulin; Tamoxifen; Triiodothyronine | 1986 |
The effect of tamoxifen therapy on thyroid function tests.
Topics: Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Tamoxifen; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1986 |
Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation.
Topics: Blotting, Northern; Cell Division; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; DNA Probes; Drug Synergism; Estradiol; Gene Expression; Humans; Insulin-Like Growth Factor I; Kinetics; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Retinoid X Receptors; Retinoids; RNA, Messenger; Tamoxifen; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin; Triiodothyronine; Tumor Cells, Cultured | 1995 |
Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Female; Growth Hormone; Ovariectomy; Rats; Rats, Inbred Strains; Tamoxifen; Thyroidectomy; Triiodothyronine | 1995 |
Estradiol and triiodothyronine increase production of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) by GH4C1 rat pituitary tumor cells.
Topics: Animals; Cell Count; Cell Division; Cell Line; Estradiol; Estrogen Antagonists; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Pituitary Gland, Anterior; Radioimmunoassay; Rats; Tamoxifen; Triiodothyronine | 1995 |
Triiodothyronine mimics the effects of estrogen in breast cancer cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Estradiol; Estrogen Antagonists; Gene Expression Regulation, Neoplastic; Glycerolphosphate Dehydrogenase; Humans; Isoenzymes; L-Lactate Dehydrogenase; Receptors, Estrogen; Receptors, Progesterone; Receptors, Thyroid Hormone; RNA, Messenger; Tamoxifen; Transforming Growth Factor alpha; Transforming Growth Factor beta; Triiodothyronine; Tumor Cells, Cultured | 1996 |
Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Topics: Animals; Body Weight; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Malate Dehydrogenase; Organ Size; Ovariectomy; Rats; Receptors, Estrogen; Receptors, Thyroid Hormone; Tamoxifen; Thyroidectomy; Triglycerides; Triiodothyronine; Uterus | 1997 |
Effect of 17 beta-estradiol, retinoic acid and tamoxifen upon primary and transplanted thyroid tumor in B6C3F1 mice fed an iodine deficient diet.
Topics: Animals; Estradiol; Female; Iodine; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pituitary Neoplasms; Tamoxifen; Thyroid Neoplasms; Thyroxine; Tretinoin; Triiodothyronine | 1997 |
Thyroid function in postmenopausal breast cancer patients treated with tamoxifen.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Breast Neoplasms; Female; Humans; Middle Aged; Postmenopause; Tamoxifen; Thyroglobulin; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1998 |
Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat.
Topics: Animals; Blood Glucose; Body Temperature; Bone Density; Estrogen Antagonists; Female; Growth Hormone; Hypothyroidism; Insulin-Like Growth Factor I; Kidney; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Tamoxifen; Triglycerides; Triiodothyronine; Uterus; Weight Gain | 1998 |
Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
Topics: Adaptor Proteins, Signal Transducing; Binding, Competitive; Carrier Proteins; Chloramphenicol O-Acetyltransferase; CREB-Binding Protein; DNA-Binding Proteins; Estradiol; Gene Expression Regulation; Genes, Reporter; Histone Acetyltransferases; Humans; Nuclear Proteins; Nuclear Receptor Coactivator 1; Nuclear Receptor Coactivator 2; Nuclear Receptor Interacting Protein 1; Nucleocytoplasmic Transport Proteins; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Thyroid Hormone; Recombinant Proteins; RNA-Binding Proteins; Tamoxifen; Titrimetry; Trans-Activators; Transcription Factor TFIIB; Transcription Factors; Transcription, Genetic; Triiodothyronine | 1999 |
Is thyroid hormone a modulator of estrogen receptor in porcine follicular cells?
Topics: Animals; Aromatase; Estradiol; Estrogen Antagonists; Female; Ovarian Follicle; Progesterone; Receptors, Estrogen; Swine; Tamoxifen; Triiodothyronine | 2000 |
Estrogen and tamoxifen interplay with T(3) in male rats: pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I.
Topics: Animals; Body Weight; Bone and Bones; Drug Interactions; Estrogens; Growth Hormone; Insulin-Like Growth Factor I; Lipid Metabolism; Male; Rats; Rats, Sprague-Dawley; Receptors, Thyroid Hormone; Selective Estrogen Receptor Modulators; Signal Transduction; Tamoxifen; Triiodothyronine | 2001 |
Persistent suppression of hepatic CYP2A1 expression and serum triiodothyronine levels by tamoxifen in intact female rats: dose-response analysis and comparison with 4-hydroxytamoxifen, fulvestrant (ICI 182,780), and 17beta-estradiol-3-benzoate.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression Regulation, Enzymologic; Liver; Organ Size; Ovary; Rats; Rats, Long-Evans; Steroid Hydroxylases; Tamoxifen; Testosterone; Thyroxine; Time Factors; Triiodothyronine; Uterus | 2002 |
Activation of estrogen response element dependent transcription by thyroid hormone with increase in estrogen receptor levels in a rat pituitary cell line, GH3.
Topics: Animals; Cell Division; Cell Line; Estradiol; Estrogen Receptor alpha; Estrogens; Gene Expression; Pituitary Gland; Rats; Receptors, Estrogen; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Tamoxifen; Transcription, Genetic; Triiodothyronine | 2004 |
Effect of conjugated equine estrogens and tamoxifen administration on thyroid gland histomorphology of the rat.
Topics: Animals; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Ovariectomy; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Tamoxifen; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2006 |
Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Cell Culture Techniques; Down-Regulation; Drug Interactions; Estradiol; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Tamoxifen; Transforming Growth Factor alpha; Triiodothyronine; Tumor Cells, Cultured | 2008 |
Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors.
Topics: Analysis of Variance; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Clone Cells; Estradiol; Estrogen Antagonists; Female; Humans; Receptors, Estrogen; Receptors, Thyroid Hormone; Tamoxifen; Triiodothyronine | 2009 |